Anavex Life Sciences Corp (AVXL)

[crescentmotor]

Apparently the market is thinking TLD for alz will never come.

It's probably unrealistic to expect the Street to add early value to a company like AVXL in the face of all the years of consistent failure to find an effective drug for AD. It's going to be a boom or bust situation we find ourselves in with AVXL when that TLD does come out.